article thumbnail

Jennifer Listgarten

Broad Institute

From 2007 to 2017 she was at Microsoft Research, through Cambridge, MA (2014-2017), Los Angeles (2008-2014), and Redmond, WA (2007-2008). Jennifer's research interests are broadly at the intersection of machine learning, applied statistics, molecular biology and science. She completed her Ph.D.

article thumbnail

A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic

Broad Institute

By Allessandra DiCorato April 25, 2024 As night fell on July 20th, 2014, genomicist Christian Happi was at home with his family in Lagos, Nigeria when he received a phone call he would never forget. On October 20th, 2014, as Ebola continued to spread in Guinea and in neighboring Liberia and Sierra Leone, WHO declared Nigeria free of Ebola.

Virus 132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gamma delta T cells: a rising star in cancer therapy

Drug Target Review

Prior to the founding of IN8bio, from 2014 to 2017, Mr Ho was the Founder and Managing Partner at AlephPoint Capital, a private healthcare investment fund. About the authors William Ho William Ho is a company Co-Founder, and has served as our President, Chief Executive Officer and Director of IN8bio since its inception.

Therapies 105
article thumbnail

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.

article thumbnail

Enhancing gene therapy with Circio

Drug Target Review

Previous employment includes the radiopharmaceutical company Algeta, which was acquired by Bayer in 2014, Aker Biomarine, and management consulting experience from the Pharma & Health Care practice of McKinsey & Company.

article thumbnail

What Limits a Genome’s Size?

Codon

But those studies were criticized in 2014 when researchers claimed that the earlier methods used “a rough biochemical approach…now considered to be unreliable for accurate genome size determinations.” The New Caledonian fork fern has clearly found a solution to this problem.

DNA 62
article thumbnail

Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

The Pharma Data

The program is being led by Sosei Heptares and progressed in collaboration with multiple companies including Syngene International, Domainex, Fidelta, o2h Discovery, Piramal, WuXi AppTec and the MRC Laboratory of Molecular Biology. 2014), 281, 4085-4096. References. Hilgenfeld, Febs J. Pillaiyar, et al, J. 2016), 59, 6595-6628.